Skip to content

Aquatic Therapy for Freezing of Gait in Parkinson's Disease Patients

Effectiveness of Aquatic Therapy for Parkinson's Disease Patients in the Context of a Multidisciplinary, Intensive Rehabilitation Treatment

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03015714
Acronym
AT-FOG
Enrollment
30
Registered
2017-01-10
Start date
2017-01-31
Completion date
2017-06-30
Last updated
2017-12-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gait Disorder, Sensorimotor, Gait Disorders, Neurologic, Parkinson Disease

Brief summary

Evaluation of the effectiveness of aquatic therapy for the treatment of freezing of gait in Parkinson's disease patients undergoing a multidisciplinary and intensive rehabilitation treatment.

Detailed description

Freezing of gait (FoG) is an often dramatic, disabling episodic gait pattern that is common in Parkinson's disease (PD). FoG highly impairs mobility, causes falls, and reduces quality of life. Given the limited effectiveness of both the dopaminergic therapy and the deep brain stimulation on this symptom, it represents a challenge in the field of rehabilitation. In the last years, some studies described the effectiveness of aquatic therapy on balance dysfunction in patients with PD, correlating it to the safe conditions offered by the aquatic environment and to the physical properties of water. Nevertheless, the issues concerning the feasibility and the effectiveness of aquatic therapy for the treatment of FoG have never been addressed before. The aquatic environment may act on the sensorial peripheral receptors, thus widely stimulating the proprioceptive system. PD patients show an altered processing of the proprioceptive information that could potentially underline FoG. The investigators aim at investigating the effects of aquatic therapy for the treatment of FoG in PD patients undergoing a Multidisciplinary Intensive Rehabilitation Treatment (MIRT), whose effectiveness on several motor and functional parameters has been already demonstrated.

Interventions

OTHERMIRT

MIRT consists of a 4-week rehabilitation program in a hospital setting, which entails four daily sessions of physical therapy for five days and one hour of physical exercise on the sixth day. On the seventh day the patient rests. The duration of each session, including recovery periods, is about one hour. The first session consists of a one-to-one session with a physical therapist. The second session includes aerobic exercises to improve balance and gait, using different devices: a stabilometric platform with visual cues, a treadmill plus and a cycloergometer. The third session consists of occupational therapy, the fourth one includes one hour of speech therapy.

OTHERMIRT-AT

Patients in the MIRT-AT group will undergo the land-based therapy described in MIRT plus three sessions per week (Monday, Wednesday, Friday) of aquatic therapy. On days of aquatic therapy the first session of MIRT was not provided. The aquatic therapy program included aerobic exercises and physical activities to improve balance, motor skills, coordination and joints mobility. The water sessions were divided into 3 phases: i) Warm Up Exercises, ii) Central session Training, iii) Cool-down.

Sponsors

Ospedale Generale Di Zona Moriggia-Pelascini
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
50 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosis of PD according to Gelb et al; * Hoehn & Yahr (H&Y) stage 2.5-3; * Presence of FOG confirmed in the patient assessment prior to participation in the study; * Stable pharmacological treatment for the last 8 weeks and during the rehabilitation period; * Mini Mental State Examination (MMSE) ≥ 24;

Exclusion criteria

* Cardiac, pulmonary, vestibular and orthopedic diseases; * Urinary incontinence; * Severe dyskinesias; * Patients treated with deep brain stimulation; * Visual deficits; * Comorbilities other than PD determining reduction of motor autonomy

Design outcomes

Primary

MeasureTime frameDescription
Freezing of Gait Questionnaire (FOGQ)4 weeksAssess FoG frequency, disturbances in gait and relationship to clinical features conceptually associated with gait and motor aspects.

Secondary

MeasureTime frameDescription
Unified Parkinson's Disease Rating Scale Part III (UPDRS III)4 weeksUPDRS subpart: clinician-scored monitored patient's motor evaluation
Unified Parkinson's Disease Rating Scale Part II (UPDRS II)4 weeksUPDRS subart: clinician-scored monitored patient's activitied daily life evaluation
Unified Parkinson's Disease Rating Scale tot (UPDRS tot)4 weeksClinician-scored monitored patient's global evaluation.
Timed Up and Go Test (TUG)4 weeksMotor-functional test for sit to stand, walking and turning evaluation
Six Minutes Walking Test (6MWT)4 weeksMotor-functional test for gait endurance
Berg Balance Scale (BBS)4 weeksMotor-functional test for balance evaluation

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026